Hippocampal Subfield Susceptibility Alterations in Mild Cognitive Impairment Revealed by 7T MRI

Gaoxing Zheng1, Fang Frank Yu1,2, Yujia Huang1

  • 1From the Advanced Imaging Research Center (G.Z., F.F.Y., Y.H., S.M., S.L.V., J.L.), UT Southwestern Medical Center, Dallas, Texas.

Abstract

Insights

Quantitative susceptibility mapping (QSM) reveals altered hippocampal subfield susceptibility in mild cognitive impairment (MCI), offering a potential early biomarker for Alzheimer's disease (AD). These changes correlate with cognitive decline.

Area of Science:

  • Neuroimaging
  • Biomarkers
  • Neurodegeneration

Background:

  • Magnetic susceptibility alterations in the hippocampus may indicate early Alzheimer's disease (AD).
  • Subfield-level evidence of these changes in mild cognitive impairment (MCI) is limited.
  • High-resolution quantitative susceptibility mapping (QSM) can investigate these alterations.

Purpose of the Study:

  • To investigate hippocampal subfield susceptibility changes in individuals with MCI using submillimeter high-resolution QSM.
  • To assess the potential of these changes as early biomarkers for neurodegeneration in AD.

Main Methods:

  • Thirteen MCI patients and thirteen cognitively normal controls (NC) underwent 7T MRI scans.
  • Quantitative susceptibility mapping (QSM) was performed, and hippocampal subfields (CA1, CA2, CA3, dentate gyrus (DG), subiculum (Sub)) were segmented.
  • Magnetic susceptibility values and differences between subfields were calculated and correlated with cognitive performance.

Main Results:

  • A distinct pattern in the hippocampal strata radiatum, lacunosum, and moleculare (SRLM) was visible in NC but blurred or absent in MCI.
  • Individuals with MCI showed significantly elevated susceptibility in the left dentate gyrus (DG) compared to NC.
  • Reduced susceptibility contrast between hippocampal subfields in MCI was associated with lower cognitive performance.

Conclusions:

  • 7T QSM detects significant susceptibility changes in hippocampal substructures in individuals with MCI.
  • These findings suggest that QSM-based hippocampal subfield analysis can serve as a potential early biomarker for Alzheimer's disease.